Novel Ligands for the Orphan Receptor GPR151 Modulate Morphine Action
Genes to Cells · 2026-05 · 31 (3)
DOI: 10.1111/gtc.70119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, online erschienen am 08.05.2026. Verfasst von Hijiri Yoshida und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Science, Graduate School of Science and Technology, Gunma University, Kiryu, Gunma, Japan. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Morphine. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science London.
Abstract (Originalsprache)
GPR151 is an orphan G‐protein‐coupled receptor expressed on specific neurons. Its expression has been reported to be upregulated in the dorsal root ganglia in mouse nerve injury models, suggesting a role in pain transmission. We used our unique ligand screening system to identify novel agonists and partial agonists for GPR151. The novel ligands, GUM3 and GUM4, have the psoralen ring and exhibited agonist activity (EC 50 = 4.1 ± 1.0 μM) and highly weak partial agonist activity (EC 50 = 0.81 ± 1.46 μM), respectively, in the [ 35 S]‐GTPγS binding assay. Both ligands induced GPR151 internalization and increased reporter gene expression in Chinese hamster ovary cells transiently expressing human GPR151 upon ligand stimulation. Activity evaluation employing structural analogs provided insights into a series of ligand structure–activity relationships. Administration of the unique ligands had no effect on thermal hyperalgesia in rats; however, an agonist and a partial agonist enhanced and attenuated the analgesic effect of morphine, respectively, when co‐administered. These findings not only reveal the physiological role of GPR151 in pain transmission but also demonstrate its potential as a novel drug target for pain control. Our findings indicate that the development of GPR151 ligands can contribute to the reduction of opioid use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Molecular Science, Graduate School of Science and Technology, Gunma University, Kiryu, Gunma, Japan.
- Department of Anesthesiology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
- Chemical Resource Development Research Unit, RIKEN Center for Sustainable Resource Science, Saitama, Japan.
- Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
- Drug Innovation Center, Graduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Osaka, Japan.
ORCID-Profile: Takashi Suto, Hiroyuki Hirano, Kazuto Nunomura, Shigeki Takeda
Förderung
- Japan Society for the Promotion of Science London
Zitieren
APA
Yoshida, H., Suto, T., Hirano, H., Osada, H., Nunomura, K., Lin, B., Saito, S., & Takeda, S. (2026). Novel Ligands for the Orphan Receptor GPR151 Modulate Morphine Action. Genes to Cells, 31(3). https://doi.org/10.1111/gtc.70119
Vancouver
Yoshida H, Suto T, Hirano H, Osada H, Nunomura K, Lin B, et al. Novel Ligands for the Orphan Receptor GPR151 Modulate Morphine Action. Genes to Cells. 2026;31(3). doi:10.1111/gtc.70119
BibTeX
@article{Yoshida2026,
author = {Yoshida, Hijiri and Suto, Takashi and Hirano, Hiroyuki and Osada, Hiroyuki and Nunomura, Kazuto and Lin, Bangzhong and Saito, Shigeru and Takeda, Shigeki},
title = {Novel Ligands for the Orphan Receptor GPR151 Modulate Morphine Action},
journal = {Genes to Cells},
year = {2026},
volume = {31},
number = {3},
doi = {10.1111/gtc.70119}
}
EUVIMED